Dr. Barbara J. Kreel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-826-7923 Fax: 570-826-7981 |
Vinaya Chakradeo, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7923 Fax: 570-808-5197 |
Margot E. Clasquin, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 675 Baltimore Dr, Wilkes Barre, PA 18702 Phone: 570-808-7923 Fax: 570-808-6337 |
James Dalton Hayes Ii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 675 Baltimore Dr, Wilkes Barre, PA 18702 Phone: 570-808-7923 |
Hassan Paknezhad, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7923 Fax: 570-808-5197 |
News Archive
Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior, the foremost society for research into all aspects of eating and drinking behavior, finds that the hormone leptin reduces food intake, in part, by activating the hippocampus, an area of the brain that controls learning and memory function. Leptin is a hormone released from fat cells that acts on the brain to inhibit feeding.
Health Care REIT, Inc. (NYSE:HCN) today announced updated financial guidance for fiscal year 2009 as a result of its recent common stock public offering. On September 1, 2009, the company announced that it agreed to sell 8,000,000 shares of its common stock in an underwritten public offering.
OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced the introduction of the Sonicaid Encore, a high performance fetal and maternal monitor that uses advanced technology for patient monitoring in labor and delivery.
A new study finds that a cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer. The results of this clinical trial, led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, appear in the August 2005 issue of the Journal of Urology.
› Verified 1 days ago